Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients

The Prostate, EarlyView.

Source: The Prostate - October 16, 2018 Category: Urology & Nephrology Authors: Yohei Sekino, Naohide Oue, Shoichiro Mukai, Yoshinori Shigematsu, Keisuke Goto, Naoya Sakamoto, Kazuhiro Sentani, Tetsutaro Hayashi, Jun Teishima, Akio Matsubara, Wataru Yasui Source Type: research